Lara M Simpson

Lara M Simpson

UNVERIFIED PROFILE

Are you Lara M Simpson?   Register this Author

Register author
Lara M Simpson

Lara M Simpson

Publications by authors named "Lara M Simpson"

Are you Lara M Simpson?   Register this Author

28Publications

1200Reads

14Profile Views

Effects of Antihypertensive Class on Falls, Syncope, and Orthostatic Hypotension in Older Adults: The ALLHAT Trial.

Hypertension 2019 10 3;74(4):1033-1040. Epub 2019 Sep 3.

From the Department of Medicine, Harvard Medical School (S.P.J., J.L.B., K.J.M.), Beth Israel Deaconess Medical Center, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.119.13445DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739183PMC
October 2019

Risk Factors Influencing Outcomes of Atrial Fibrillation in ALLHAT.

J Natl Med Assoc 2018 Aug 24;110(4):343-351. Epub 2017 Jul 24.

W T Dahms Clinical Research Unit, University Hospitals Case Medical Center, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jnma.2017.07.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108439PMC
August 2018

Pharmacologic Prevention of Incident Atrial Fibrillation: Long-Term Results From the ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).

Circ Arrhythm Electrophysiol 2017 Dec;10(12)

From the Knight Cardiovascular Institute, Oregon Health & Science University, Portland (T.A.D.); Cardiology Section, Department of Internal Medicine, Wake Forest School of Medicine, Winston Salem, NC (E.Z.S.); University of Texas School of Public Health, Houston (J.-M.Y., B.R.D., L.M.S.); Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA (A.A.); Center for Arrhythmia Prevention, Division of Preventive Medicine and Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (C.M.A.); Keck School of Medicine, University of Southern California, Los Angeles (L.J.H.); and Electrophysiology Section, Division of Cardiology, Department of Medicine, University of California, San Francisco (G.M.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCEP.117.005463DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728652PMC
December 2017

The Association Between Antihypertensive Medication Nonadherence and Visit-to-Visit Variability of Blood Pressure: Findings From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

Hypertension 2016 07 23;68(1):39-45. Epub 2016 May 23.

From the Center for Behavioral Cardiovascular Health, Columbia University Medical Center, New York, NY (I.M.K.); Department of Epidemiology (A.I.L., P.M.) and Division of Cardiology (S.O.), University of Alabama at Birmingham; Primary Care Division, Clement J. Zablocki VA Medical Center, Milwaukee, WI (J.W.); Coordinating Center for Clinical Trials, The University of Texas School of Public Health, Houston (B.R.D., L.M.S.); Department of Medicine, Tulane University School of Medicine, Department of Epidemiology, Tulane University School of Public Health, and Tropical Medicine, Research Division, Ochsner Health System (M.K.-W.); Preventive Medicine Section, Veterans Affairs Medical Center, Memphis, TN (W.C.C.); and Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA (T.I.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.115.06960DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900942PMC
July 2016

Visit-to-Visit Variability of BP and CKD Outcomes: Results from the ALLHAT.

Clin J Am Soc Nephrol 2016 Mar 18;11(3):471-80. Epub 2016 Feb 18.

Departments of Epidemiology and Medicine, University of Alabama, Birmingham, Alabama;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.04660415DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791814PMC
March 2016

Effect of chlorthalidone, amlodipine, and lisinopril on visit-to-visit variability of blood pressure: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

J Clin Hypertens (Greenwich) 2014 May 16;16(5):323-30. Epub 2014 Apr 16.

Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jch.12290DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141643PMC
May 2014

Glycated hemoglobin measurement and prediction of cardiovascular disease.

JAMA 2014 Mar;311(12):1225-33

University of Cambridge, Cambridge, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2014.1873DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386007PMC
March 2014

The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis.

Am Heart J 2007 Jan;153(1):42-53

National Heart, Lung, and Blood Institute, Division of Epidemiology and Clinical Applications, Bethesda, MD 20892-7936, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2006.10.012DOI Listing
January 2007